scispace - formally typeset
D

D. Schuring

Researcher at Eindhoven University of Technology

Publications -  22
Citations -  813

D. Schuring is an academic researcher from Eindhoven University of Technology. The author has contributed to research in topics: Quality assurance & Computer science. The author has an hindex of 10, co-authored 18 publications receiving 762 citations.

Papers
More filters
Journal ArticleDOI

Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer : report from the Quality Assurance Working Party of the randomised phase III ROSEL study

TL;DR: These guidelines can serve to facilitate the design of future multi-centre clinical trials of stereotactic radiotherapy in other patient groups and aid a more uniform implementation of this technique outside clinical trials.
Journal ArticleDOI

Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume

TL;DR: The 4D accumulated dose delivered to the CTV in stereotactic radiotherapy of lung tumours, for treatments planned on an average CT using an ITV derived from the Maximum Intensity Projection (MIP) CT is determined.
Journal ArticleDOI

High precision bladder cancer irradiation by integrating a library planning procedure of 6 prospectively generated SIB IMRT plans with image guidance using lipiodol markers.

TL;DR: Using the library planning approach combined with online image guidance using lipiodol markers, the protocol was able to deliver a highly conformal dose distribution to all bladder cancer patients achieving promising clinical results.
Journal ArticleDOI

Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose

TL;DR: Inhomogeneity corrections have a large influence on the dose delivered to the PTV and OARs for SBRT of lung tumors, implicating that accurate dose calculations are necessary for these treatment plans in order to prevent large discrepancies between planned and actually delivered doses to individual patients.